Cargando…
Top-down MS for rapid methionine oxidation site assignment in filgrastim
Protein therapeutics have emerged as a major new class of pharmaceuticals. One important shelf-life-limiting factor of biopharmaceuticals is methionine oxidation, and therefore, it is important that analytical methods are able to thoroughly characterize all possible oxidized variants. Here, we prese...
Autores principales: | Holzmann, Johann, Hausberger, Anna, Rupprechter, Alfred, Toll, Hansjoerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730093/ https://www.ncbi.nlm.nih.gov/pubmed/23831755 http://dx.doi.org/10.1007/s00216-013-7138-0 |
Ejemplares similares
-
Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
por: Sörgel, Fritz, et al.
Publicado: (2015) -
The structure-function relationship of disulfide bonds in etanercept
por: Lamanna, William C., et al.
Publicado: (2017) -
Filgrastim, fibrinolysis, and neovascularization
por: Eton, Darwin, et al.
Publicado: (2022) -
Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization
por: Husian, Sadik, et al.
Publicado: (2021) -
The Safety Profile of Filgrastim and Pegfilgrastim
por: Neumann, Theresa A., et al.
Publicado: (2011)